Attached files
| file | filename |
|---|---|
| EX-99.3 - UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET AS OF JUNE 30, 2019 AND STA - AYTU BIOPHARMA, INC | f8k021320ex99-3_aytubio.htm |
| 8-K - CURRENT REPORT - AYTU BIOPHARMA, INC | f8k021320_aytubioscience.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in the Form 8-K, constituting a part of this Current Report, of our report dated April 1, 2019, relating to the consolidated financial statements of Innovus Pharmaceuticals, Inc., as of December 31, 2018 and 2017, which is incorporated by reference in the Form 8-K.
/s/ Hall & Company Certified Public Accountants & Consultants, Inc.
Irvine, CA
February 14, 2020